MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells
β Scribed by Tanaka, Motoyoshi; Koul, Dimpy; Davies, Michael A; Liebert, Monica; Steck, Peter A; Grossman, H Barton
- Book ID
- 110064230
- Publisher
- Nature Publishing Group
- Year
- 2000
- Tongue
- English
- Weight
- 233 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The purpose of these experiments was to assess the synergistic activity of silibinin with chemotherapy agents in clinical use against prostate cancer. Silybinβphytosome, a commercially available formulation containing silibinin, has recently been studied in a phase I clinical trial. The
Polypeptide growth factors are positive and negative regulators of prostatic growth and function, and many positive regulators of growth in the prostate have been extensively studied. However, very few inhibitors of prostate cell proliferation have been identified. We have isolated a unique 18-kDa s